Data last refreshed 95 days ago — analysis may not reflect the latest market data

VRSN

NEUTRAL

$270.41

P/E

30.72

PEG

0.03

FCF Yield

Rev Growth YoY

+637.0% YoY

Gross Margin

8815.0%

Health Score

4/10

D/E Ratio

0.86

Confidence

LOW


Advertisement

Business Snapshot

The ticker and exchange data provided in this payload are incomplete, making a precise business description impossible. What can be observed is that this appears to be a very small or micro-cap entity given the data profile, trading at $270.41 per share with no market capitalisation figure available. The company operates in an unidentified sector and industry, which significantly limits the ability to contextualise its financial metrics within a peer group.

Advertisement

Financial Health

Score: 4/10

The financial health picture is deeply unusual and warrants caution. Gross margins of 8,815% and a net margin of 4,984% are not plausible figures for any conventional business — these numbers likely reflect an extremely small revenue base where a tiny absolute profit produces astronomically distorted percentage margins, rather than genuine operational excellence...

Risk Assessment

  • DATA INTEGRITY: Gross margin of 8,815% and net margin of 4,984% are statistically implausible and suggest either a near-zero revenue base or data anomalies — neither interpretation is reassuring.
  • LIQUIDITY: Current ratio of 0.49x indicates current liabilities exceed current assets, raising near-term solvency concerns.
  • CASH FLOW: Free cash flow is unavailable; without confirmed positive FCF, the business cannot be assessed for self-sustainability.
  • EARNINGS TRACK RECORD: The company has beaten earnings estimates in 0 of its last 4 reported quarters, suggesting either consistently poor execution or unreliable estimate consensus.
  • TECHNICAL DETERIORATION: A confirmed "death cross" (50-day MA crossing below 200-day MA) is a bearish technical signal, and the MACD is also bearish — both indicators point to negative price momentum.

---...

**Score: 4/10** The financial health picture is deeply unusual and warrants caution. Gross margins of 8,815% and a net margin of 4,984% are not plausible figures for any conventional business — these numbers likely reflect an extremely small revenue base where a tiny absolute profit produces astronomically distorted percentage margins, rather than genuine operational excellence. The current ratio of 0.49x is concerning, meaning the company has less than $0.50 in current assets for every $1.00 of current liabilities, indicating potential short-term liquidity stress. Free cash flow is unavailable, making it impossible to assess whether the business generates real cash, which is the single most important measure of financial health. ---

- **DATA INTEGRITY:** Gross margin of 8,815% and net margin of 4,984% are statistically implausible and suggest either a near-zero revenue base or data anomalies — neither interpretation is reassuring. - **LIQUIDITY:** Current ratio of 0.49x indicates current liabilities exceed current assets, raising near-term solvency concerns. - **CASH FLOW:** Free cash flow is unavailable; without confirmed positive FCF, the business cannot be assessed for self-sustainability. - **EARNINGS TRACK RECORD:** The company has beaten earnings estimates in 0 of its last 4 reported quarters, suggesting either consistently poor execution or unreliable estimate consensus. - **TECHNICAL DETERIORATION:** A confirmed "death cross" (50-day MA crossing below 200-day MA) is a bearish technical signal, and the MACD is also bearish — both indicators point to negative price momentum. ---

Unlock the full AI report

Full 8-section analysis includes:

Financial Health
Growth Momentum
Valuation Snapshot
Risk Flags
Sentiment & News
Technical Snapshot
Full Verdict with Confidence Rating
Last updated 2294 hours ago · Data sourced from FMP & Finnhub · Not financial advice